SBP-9330
SBP 9330 is an investigational small-molecule drug and a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), being developed as a potential treatment for nicotine dependence and other substance-use…
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
SBP 9330 is an investigational small-molecule drug and a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), being developed as a potential treatment for nicotine dependence and other substance-use disorders.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374785084 under CC BY-SA 4.0; modifications have been made.